Kenneth Hughes
Direttore operativo presso MICROBIX BIOSYSTEMS INC.
Patrimonio netto: 106 015 $ in data 31/05/2024
Posizioni attive di Kenneth Hughes
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Direttore operativo | 03/06/2019 | - |
| Roker Biotechnologies, Inc. | Fondatore | 01/01/2010 | - |
| Presidente | 01/01/2010 | - |
Storia della carriera di Kenneth Hughes
Precedenti posizioni note di Kenneth Hughes
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Itp Biomedica Corp. | Amministratore Delegato | 01/01/2014 | 01/01/2019 |
| Presidente | 01/01/2014 | 01/01/2019 | |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 | 01/01/2013 |
| MICROBIX BIOSYSTEMS INC. | Direttore Tecnico/Scientifico/R&S | 01/01/1995 | 01/01/2010 |
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Fondatore | 01/01/2008 | - |
Hemosol Corp. /Old/
 Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Corporate Officer/Principal | - | - |
Formazione di Kenneth Hughes
| University of London | Doctorate Degree |
| The University of Sheffield | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Canada | 7 |
| Regno Unito | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| President | 2 |
| Founder | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MICROBIX BIOSYSTEMS INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Health Technology |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Health Technology |
| Itp Biomedica Corp. | |
| Roker Biotechnologies, Inc. |
- Borsa valori
- Insiders
- Kenneth Hughes
- Esperienza
